Incidence of vancomycin-resistant Enterococcus at a university hospital in Brazil

被引:15
作者
Furtado, GHC [1 ]
Martins, ST [1 ]
Coutinho, AP [1 ]
Soares, GMM [1 ]
Wey, SB [1 ]
Medeiros, EAS [1 ]
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Doencas Infecciosas & Parasitarias, Sao Paulo, Brazil
来源
REVISTA DE SAUDE PUBLICA | 2005年 / 39卷 / 01期
关键词
strepto-enterococcus; Vancomycin resistance; epidemiologic measurements; University hospitals;
D O I
10.1590/S0034-89102005000100006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective Vancomycin-resistant Enterococcus (VRE) is today one of the principal microorganisms implicated in nosocomial infections. Thus, a study was carried out with the objective of evaluating its epidemiology at a tertiary-level teaching hospital. Methods This was a three-year retrospective epidemiological study conducted from 2000 to 2002. Samples of VRE-positive clinical cultures at a 660-bed university hospital were analyzed. The incidence of VRE and the main anatomical sites and hospital units from which it was isolated were defined. Differences between the variables over the three years of the study were verified, and these were considered significant when p < 0.05. Results There was a progressive increase in the vancomycin resistance in the clinical cultures that were positive for Enterococcus spp., over the three years of the study. In 2000, 9.5% of the samples were vancomycin-resistant, and this increased to 14.7% in 2001 and 15.8% in 2002. The hospital units with the largest numbers of isolates were, respectively, the emergency ward (19.5%) and the general intensive care unit (15%). The anatomical sites with the highest amounts of isolates included: urine (36%) and blood (20%). Conclusions With the progressive increase in the incidence of vancomycin resistance and the VRE rate, it is concluded that more effective control measures are needed for deterring the dissemination of VRE.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 23 条
[1]   Vancomycin-resistant Enterococcus - Detection, epidemiology, and control measures [J].
Boyce, JM .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (02) :367-&
[2]   A hospital epidemic of vancomycin-resistant Enterococcus:: Risk factors and control [J].
Byers, KE ;
Anglim, AM ;
Anneski, CJ ;
Germanson, TP ;
Gold, HS ;
Durbin, LJ ;
Simonton, BM ;
Farr, BM .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (03) :140-147
[3]  
Centers for Disease Control and Prevention, 1998, MMWR-MORBID MORTAL W, V46, p[ii, 3]
[4]  
Cereda, 1997, Braz J Infect Dis, V1, P83
[5]  
Cereda R, 2001, Braz J Infect Dis, V5, P40, DOI 10.1590/S1413-86702001000100007
[6]  
DALLACOSTA LM, 1998, BRAZ J INFECT DIS, V2, P160
[7]   Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin [J].
Eliopoulos, GM ;
Wennersten, CB ;
Gold, HS ;
Schülin, T ;
Souli, M ;
Farris, MG ;
Cerwinka, S ;
Nadler, HL ;
Dowzicky, M ;
Talbot, GH ;
Moellering, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1088-1092
[8]  
Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1
[9]   Drug therapy - Antimicrobial-drug resistance [J].
Gold, HS ;
Moellering, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) :1445-1453
[10]   Vancomycin-resistant enterococci: Mechanisms and clinical observations [J].
Gold, HS .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :210-219